Importance of Quality Assurance

When one ingredient shuts down global supply chains The global recall of infant formula by Nestlé, Danone, and Lactalis Group reveals a deeper structural issue: supply chains in high-trust, highly regulated industries remain dangerously exposed to single points of failure. A contaminated batch of ARA oil — a critical ingredient sourced from China — triggered recalls across Europe, Asia, and Latin America. The incident is now a global food safety crisis, but the real headline is this: one supplier, one ingredient, and three multinationals scrambling to respond. This raises critical structural questions: - Why do complex, tech-enabled supply chains still lack true end-to-end traceability? - How did supplier concentration risks go unaddressed in such a sensitive product category? - Where is the operational resilience when public trust, brand equity, and infant health are on the line? Capital markets reacted immediately: - Danone stock dropped 12% in mid-January, reaching a one-year low. - Nestlé lost nearly 10% off December highs. - Share price volatility remains elevated as regulators expand investigations. The infant formula market is worth over USD 55 billion globally. It operates on thin margins, tight regulations, and high consumer sensitivity. This crisis is a signal — not just for food manufacturers, but for any global player relying on niche raw materials. When supply chains are global, resilience cannot be local. #retail #fmcg #ecommerce #supplychain #infantnutrition #recall #qualitycontrol #traceability #resilience #riskmanagement #supplierdiversity #brandtrust #rawmaterials #foodtech #retaitech #manufacturing #china #france #switzerland #europe #productrecall #nestle #danone #lactalis #globaltrade #consumertrust #foodindustry #araoil #cereulide #stockmarket #operations #logistics

📏 Before trusting the data, we must first trust the measurement system. In quality and manufacturing, many important decisions are based on measurements: accepting or rejecting parts, releasing product, adjusting processes, investigating defects, or responding to customer concerns. But there is one question we sometimes overlook: How reliable is our measurement system? That is where Gage R&R comes in. This tool helps us evaluate whether the variation we are seeing comes from the actual process or if it is being introduced by the measuring instrument, the method, or the people performing the measurement. In my experience, a well-executed Gage R&R study provides clear benefits: ✅ Improves data reliability ✅ Reduces wrong decisions caused by measurement error ✅ Helps validate instruments, methods, and appraisers ✅ Strengthens process capability studies such as Cp and Cpk ✅ Supports PPAP, MSA, audits, and continuous improvement activities ✅ Identifies repeatability and reproducibility issues before they impact the customer Some examples of when to use it: 🔹 When introducing a new measuring instrument 🔹 When different operators measure the same characteristic 🔹 Before conducting process capability studies 🔹 During new product or process validations 🔹 When there are discrepancies between inspection, production, and customer results 🔹 When you need to ensure that the data used for decision-making is reliable For me, Gage R&R is not just a technical requirement. It is a way to protect the quality of our decisions. Because if the measurement system is not reliable, the data won’t be reliable either. And if the data is not reliable, any improvement effort may be built on a weak foundation. 📌 A good measurement system is the starting point for reliable decisions. What has been more challenging in your experience: the instrument, the method, or the variation between appraisers? #GageRR #MSA #Quality #ContinuousImprovement #Manufacturing #IndustrialEngineering #SPC #SixSigma #ProcessCapability #QualityEngineering

Trust without verification isn’t trust. It’s roulette. The Anker PowerCore recall is still on my mind—not just because it’s a big story, but because it highlights something we all know yet constantly overlook: supply chain transparency. I’ve been following the story closely. In China, it’s big news. A leading battery cell supplier, Apex (Wuxi), quietly changed the cathode material (and possibly separator properties) without notifying its customers. The result? Thermal runaway incidents, recalls across continents, a lost 3C certification, and a market that’s now questioning the brand’s batteries. Here’s the part that sticks with me: Anker had to reverse-engineer their own supplier’s parts to discover the changes. They tested cells, tracked variations in nickel, cobalt, and manganese ratios over time, saw separator tensile strength shift — and still got stonewalled until they had hard proof in hand. The thing is, this is not a “bad supplier” story. This is a normal supplier story. The best suppliers make changes — to improve yield, lower cost, meet demand — and those changes can introduce risks no one sees until the field data starts coming in hot. And here’s the uncomfortable truth: if your only quality control is taking your supplier’s word for it, you will miss things. You will end up with defects in the field. You will be blindsided. Zero trust in manufacturing isn’t about paranoia — it’s about instrumentation. It’s about building systems where you can independently verify what’s being built, with what materials, on which machines, under which conditions. It’s about assuming nothing until you’ve seen it with your own eyes (or your own sensors). Because real trust — the kind that survives recalls and crises — isn’t given at the start of a contract. It’s built, piece by piece, over time, as both sides operate with transparency and accountability. When you don’t have that, you’re not running a supply chain — you’re playing roulette. Quality and supply chain leaders, in your experience, what’s the most effective way to detect a supplier change before it becomes a costly problem? #ElectronicsManufacturing #SupplyChainManagement #ProductQuality #SupplyChainTransparency

Testing isn’t about proving what works—it’s about uncovering what breaks before the user does. Strong QA practices go beyond checklists. They anticipate risks, challenge assumptions, and protect user trust. > Test like a real user, in real conditions > Start testing early—shift left to catch issues sooner > Automate repetitive and regression checks to save time and reduce Human error > Prioritize high‑risk, high‑impact areas where failures matter most > Keep test cases clear, concise, and easy to maintain > Validate across different environments, browsers, and devices > Use realistic, imperfect data to simulate real‑world scenarios > Recheck fixes to prevent regressions from creeping back in > Explore creatively to uncover unexpected issues > Push the system’s limits to reveal hidden weaknesses Quality isn’t just about passing tests—it’s about building confidence in the product. When QA is treated as a strategic partner, teams deliver not only faster but smarter, with fewer surprises in production. #QAEngineering #SoftwareTesting #QualityMatters #TechCulture #Automation

Today, FDA published its weekly list of recent Warning Letters. This Warning Letter to ASP Global only cited one QMS area - purchasing controls, while also citing violations related to the MDR regulation, Corrections and Removals regulation, and a failure to get clearance before marketing a significantly changed device. This one statement in sub-section C of citation 1 (Purchasing Controls) struck me as particularly interesting: "C. (b)(4) [the supplier] was audited by FDA in (b)(4) and received four observations, but ASP Global was not notified until April 29, 2025, after (b)(4) was placed on Import Alert, despite working closely with (b)(4) on SCAR-339 from February to March 2025. The ASP/(b)(4) Quality Agreement, Section 2.3, Page 6 of 15, states "(b)(4) shall notify ASP in writing within (b)(4) if any of the following occurs: (c) (b)(4) becomes aware of any inspection or audit findings that affect safety, effectiveness, conformity, or availability of product."" Effectively, ASP Global was cited in the Warning Letter because its supplier failed to notify it of the outcome of an FDA inspection (i.e., import alert) despite a requirement to provide such notification in the Supplier Quality Agreement (SQA). Initially, it seems unfair that FDA would cite a firm for something its supplier failed to do, but it speaks to a very important need within supplier quality teams at medical device manufacturers. SQAs cannot be once-and-done documents. The ongoing monitoring of suppliers (21 CFR 820.50 and ISO 13485:2016, clauses 4.1.5, 7.4.2) must include ensuring that the supplier is meeting all of its obligations under the SQA. As we see from this WL, FDA may hold you accountable for a supplier not complying with an SQA if they feel you haven't done your job in enforcing its provisions. https://lnkd.in/gsQ-cyjZ

A QA engineer at a fintech startup in Hyderabad spotted a bug. It affected only one test account out of 10. She logged it, but marked it low-priority — “unlikely to affect production.” Another QA at an e-commerce company in Noida saw a similar issue. The bug showed up in 1 out of 10 flows. He flagged it but didn’t escalate — “edge case, let’s revisit after sign-off.” Meanwhile, a QA at Amazon noticed a similar defect. It reproduced in only 10% of accounts. But something felt off. Instead of brushing it off, → he pulled legacy data → traced backend configs → simulated multiple scenarios. What he found shocked everyone. That “10%” included the company’s top-paying enterprise clients. Had it gone live, the business would’ve lost contracts, trust, and revenue. So the team halted release. Fixed the issue. And avoided a high-impact escalation. Honestly, this isn’t the first time I’ve seen this happen. It’s happened to me multiple times The bugs that look harmless at first are often the ones that quietly break production later. That’s why I’ve made it a habit: If something feels off, I don’t ignore it. I dig deeper. I ask why. Even if it’s “just one account.” Now you see 3 QAs Same type of bug Only one saw the full picture Not because he had better tools. But because he thought beyond the obvious. Great QA isn’t about catching bugs. It’s about understanding risk. And sometimes, that “one-off” bug is just the tip of something way bigger. The best QAs don’t test features. They test assumptions. And that’s what protects the product before things break. P.S. I'm Raghvendra - a QA II at Amazon.  Follow me for more insights on QA, SDET, and engineering daily.  

Walking through our Geotechnical Monitoring Center at Vale Base Metals in Brazil, what stood out to me was the maturity of how monitoring is understood. People tend to see it as a layer of control, something that tells you when something is wrong. But what I see in our GMC, leading extraordinarily by Felipe Campolina Barbosa is much closer to a system that teaches how assets behave over time. Instrumentation data is used to build a “memory” of the structure as Simone Sousa has showed. A way to understand what “normal” actually looks like, so that deviations are interpreted with context. And that changes how you manage risk, because uncertainty is reduced when you move from static assumptions to a dynamic understanding, connecting design intent with operational behavior. In the end, good monitoring is less about technology and more about right judgment. Sensors don’t manage risk. People do, using better information, at the right time, with the right questions.

I ONCE COST MY COMPANY $340,000 BECAUSE I SAVED $2 PER UNIT. It was 2019. I chose the cheapest supplier for a critical component. The spreadsheet looked perfect. My ROI calculation was a work of art. Three months later, a quality control failure triggered a massive recall. The $2 savings per unit didn't just disappear—it turned into a $340,000 nightmare of logistics, penalties, and lost customer trust. I haven't made that mistake since. When I talk to COOs today, I see them under extreme pressure to cut costs. But here is the blood-and-sweat reality: A bankrupt or low-quality supplier stops your production line cold. Procurement isn’t a back-office service. It’s an insurance policy for your continuity. My rule of thumb now: I evaluate the "Worst Month," not the "Best Month." I want to know how the supplier recovers when the world is on fire, not how they perform when everything is smooth. Are you still rewarding your team for finding the lowest price, or for finding the most resilient partner? #SupplyChainRisk #COO #ManufacturingExcellence #LessonsLearned

“Do you know what you get when you spend $30 on a suit?” A $30 suit. I learned that lesson the hard way when the royal‑blue bargain I scored at TJ Maxx split at the seam before I’d finished zipping the jacket. My husband just raised an eyebrow: “You got exactly what you paid for.” Procurement faces the same trap. Chasing the lowest line‑item price feels like a win, until the hidden costs show up on the P&L. Here are the real costs of pool quality: Rework & scrap – internal failure costs, extra labor, wasted materials. Many firms see quality‐related costs eat 15‑20 % of revenue. External failures – returns, warranty claims, recalls. Supplier issues drive can drive 60%+ of product recalls, eroding profit and trust. Expedited freight & overtime – scrambling to replace defective stock blows up logistics budgets. Line stoppages & missed launch windows – each hour of downtime multiplies the “savings” into losses. Brand damage – a single recall can be in the many millions in the U.S. before reputational fallout. Opportunity cost – teams locked in “fire‑fighting” mode have no bandwidth for innovation or growth projects. Fit‑for‑purpose beats rock‑bottom price every time. Great procurement professionals evaluate Total Cost of Ownership: Prevention – supplier audits, spec alignment, robust contracts. Appraisal – first‑article inspection, in‑process checks, SPC dashboards. Failure avoidance – dual sourcing, safety stock, clear remediation clauses. Yes, quality programs cost money up front. But the alternative is paying the price of non‑conformance, often in multiples of the original “savings.” Next time someone waves a bargain in front of you, remember my royal blue suit. Ask: Will this supplier’s quality help us hit plan, protect the brand, and free cash to grow? If the answer is no, the cheapest option is the most expensive one. What's your version of the cheap royal blue suit? Share in the comments. -------------- If you're enjoying these insights, follow me here on LinkedIn for more on supply chain strategy, procurement transformation, and building antifragile operations. 📘 My book Antifragile Supply Chains shares practical frameworks and real‑world stories to help you turn disruption into competitive advantage. Now available on Amazon